References
1. Bae GY, Lee HW, Chang SE, et al. Clinicopathologic review of 19
patients with systemic candidiasis with skin lesions. Int J
Dermatol . Jul 2005;44(7):550-5. doi:10.1111/j.1365-4632.2004.02006.x
2. Faria DR, Sakita KM, Capoci IRG, et al. Promising antifungal activity
of new oxadiazole against Candida krusei. PLoS One .
2020;15(1):e0227876. doi:10.1371/journal.pone.0227876
3. Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia
and invasive candidiasis in adults: A narrative review. Eur J
Intern Med . Oct 2016;34:21-28. doi:10.1016/j.ejim.2016.06.029
4. Muñoz P, Sánchez-Somolinos M, Alcalá L, Rodríguez-Créixems M, Peláez
T, Bouza E. Candida krusei fungaemia: antifungal susceptibility and
clinical presentation of an uncommon entity during 15 years in a single
general hospital. J Antimicrob Chemother . Feb 2005;55(2):188-93.
doi:10.1093/jac/dkh532
5. Hager JL, Mir MR, Hsu S. Candida krusei fungemia in an
immunocompromised patient. Dermatol Online J . Apr 15
2010;16(4):5.